TMCAX
Price
$12.07
Change
-$0.33 (-2.66%)
Updated
Feb 21 closing price
Net Assets
156.31M
VEXPX
Price
$114.19
Change
-$3.28 (-2.79%)
Updated
Feb 21 closing price
Net Assets
22.89B
Ad is loading...

TMCAX vs VEXPX

Header iconTMCAX vs VEXPX Comparison
Open Charts TMCAX vs VEXPXBanner chart's image
RBC SMID Cap Growth A
Price$12.07
Change-$0.33 (-2.66%)
VolumeN/A
Net Assets156.31M
Vanguard Explorer I
Price$114.19
Change-$3.28 (-2.79%)
VolumeN/A
Net Assets22.89B
TMCAX vs VEXPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
TMCAX vs. VEXPX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TMCAX is a Hold and VEXPX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEXPX has more cash in the bank: 22.9B vs. TMCAX (156M). VEXPX pays higher dividends than TMCAX: VEXPX (0.48) vs TMCAX (0.00). TMCAX was incepted earlier than VEXPX: TMCAX (31 years) vs VEXPX (57 years). VEXPX is a more actively managed with annual turnover of: 40.00 vs. TMCAX (25.00). TMCAX has a lower initial minimum investment than VEXPX: TMCAX (1000) vs VEXPX (3000). VEXPX annual gain was more profitable for investors over the last year : 0.58 vs. TMCAX (0.24). VEXPX return over 5 years is better than : 6.78 vs. TMCAX (-6.63).
TMCAXVEXPXTMCAX / VEXPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence31 years57 years-
Gain YTD-1.665-0.661252%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets156M22.9B1%
Annual Yield % from dividends0.000.48-
Returns for 1 year0.240.5842%
Returns for 3 years1.643.2351%
Returns for 5 years-6.636.78-98%
Returns for 10 years-15.5317.94-87%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WSR13.32-0.13
-0.97%
Whitestone REIT
MVO5.33-0.16
-2.91%
MV Oil Trust
FFIV295.56-9.04
-2.97%
F5, Inc.
ARWR19.90-1.06
-5.06%
Arrowhead Pharmaceuticals
MGRX4.33-0.39
-8.26%
Mangoceuticals Inc